TG Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | +0.0% | +0.0% | +0.0% | 0.0% | -0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +1,986.8% | +94.8% | +31.4% | +14.3% | -13.1% | -70.5% | -84.2% | -14.9% | +9,653.8% | +106.0% | +931.6% | -73.5% | +44.4% | +15.7% | +14.2% | +29.0% | +11.7% | +16.8% | +14.6% | +19.1% | +6.4% | +17.3% | – | |
| – | +316,485.7% | -100.0% | +2.7% | +11.1% | -1.7% | +34.0% | +6.7% | -22.6% | -100.0% | – | – | – | – | – | – | – | – | +31.1% | +6.5% | +97.3% | -28.1% | +12.9% | -90.3% | -91.3% | +50.0% | +28,466.7% | +123.0% | +83.6% | +126.4% | -30.5% | +50.4% | +12.5% | +64.9% | +0.9% | +21.9% | +48.7% | +35.5% | -12.1% | +22.9% | – | |
| – | -207,289,815.2% | – | +0.0% | +0.0% | 0.0% | -0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -444,881.6% | – | +0.0% | +0.0% | -278.9% | – | +113.6% | +24.4% | +21.5% | -15.7% | -67.9% | -83.9% | -16.3% | +8,920.8% | +103.9% | +1,046.0% | -77.8% | +60.9% | +12.4% | +14.4% | +24.5% | +13.5% | +16.0% | +9.3% | +15.6% | +11.0% | +16.2% | – | |
| – | +2.6% | -4.9% | +24.9% | -0.4% | +1.6% | +25.0% | +17.6% | -13.4% | +55.9% | -39.5% | +2.0% | +79.3% | -47.9% | +22.3% | +1.2% | +38.5% | -14.9% | +46.9% | -28.9% | +15.8% | +20.5% | -23.3% | -44.1% | -22.6% | +42.5% | -46.4% | +41.5% | -34.3% | +18.3% | +87.5% | -46.3% | +14.7% | +18.6% | +94.2% | -31.4% | +28.6% | +0.8% | +17.5% | +97.0% | – | |
| – | -43.7% | +181.7% | -65.0% | +154.6% | +13.5% | +29.9% | -13.9% | -83.0% | +97.5% | +100.4% | +6.2% | +8.1% | +94.4% | +66.9% | +1.2% | +144.5% | +40.7% | -46.1% | +27.1% | +2.6% | -7.1% | -36.4% | -38.7% | +12.8% | +57.9% | +24.7% | +29.6% | -9.9% | +3.8% | +1.7% | +12.2% | +8.2% | -7.2% | +29.2% | +10.4% | +13.9% | -0.9% | +40.6% | -6.9% | – | |
| – | -3.6% | +15.1% | +2.7% | +11.1% | -1.7% | +33.9% | +6.7% | -22.6% | +57.7% | -35.9% | +2.5% | +71.2% | -37.6% | +32.3% | +1.2% | +68.5% | +1.1% | +3.6% | -12.2% | +10.1% | +9.4% | -27.8% | -42.4% | -11.3% | +48.7% | -15.7% | +33.9% | -19.2% | +2.1% | +38.6% | -16.2% | +10.2% | +1.2% | +53.9% | -9.6% | +19.3% | -0.2% | +31.4% | +29.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -110.9% | – | – | +41.0% | +140.9% | -71.2% | +304.1% | -15.7% | +72.0% | -31.1% | -37.7% | – | |
| – | +218.9% | -100.0% | – | – | – | – | – | -0.9% | +387.3% | -28.1% | +39.1% | +42.7% | +23.6% | -36.8% | +85.5% | -27.7% | -19.8% | +47.0% | -14.5% | -36.0% | +3.9% | +146.9% | +13.3% | -45.4% | +73.7% | -0.6% | +27.5% | +2.4% | -34.5% | -5.9% | +73.8% | +172.4% | -34.8% | -4.3% | -0.6% | +0.1% | -2.8% | +17.3% | +116.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.3% | – | – | -34.8% | +496.4% | -78.5% | +465.5% | -16.2% | +74.0% | -54.8% | -49.7% | – | |
| – | – | – | -218.3% | – | – | – | – | – | – | – | +43.3% | +59.8% | +50.7% | -45.9% | +134.1% | -29.3% | -0.3% | -0.7% | -29.5% | -49.4% | -23.2% | +447.6% | -26.7% | -45.5% | +8.8% | -164.9% | – | -103.5% | – | -92.6% | -1,231.0% | – | +446.9% | -80.8% | +569.9% | -13,454.8% | – | -97.3% | +318.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -112.7% | – | – | -43.6% | +501.3% | -78.3% | +457.1% | +1,286.8% | -94.1% | -14.2% | -60.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -109.8% | – | – | +43.1% | +114.8% | -62.3% | +206.9% | -13.3% | +58.1% | -45.6% | -22.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.